Responses to Crizotinib Can Occur in C-Met Overexpressing Nonsmall Cell Lung Cancer After Developing EGFR-TKI Resistance

Cancer Biology and Therapy - United States
doi 10.1080/15384047.2018.1523851
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy